IRIS
SALOMONE, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.429
EU - Europa 4.810
AS - Asia 4.549
SA - Sud America 783
AF - Africa 577
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 20.168
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.088
SG - Singapore 2.336
RU - Federazione Russa 1.450
CN - Cina 1.218
IT - Italia 1.058
IE - Irlanda 729
BR - Brasile 637
UA - Ucraina 616
VN - Vietnam 401
CA - Canada 272
CI - Costa d'Avorio 252
FR - Francia 241
DE - Germania 185
SN - Senegal 130
SE - Svezia 120
KR - Corea 102
GB - Regno Unito 100
IN - India 97
NG - Nigeria 91
FI - Finlandia 54
BD - Bangladesh 49
AR - Argentina 44
HK - Hong Kong 44
MX - Messico 39
ID - Indonesia 37
NL - Olanda 37
JP - Giappone 36
PL - Polonia 35
ZA - Sudafrica 33
IQ - Iraq 32
ES - Italia 30
TR - Turchia 29
PK - Pakistan 28
GR - Grecia 24
BE - Belgio 23
EC - Ecuador 23
UZ - Uzbekistan 23
CH - Svizzera 20
KE - Kenya 20
CO - Colombia 19
IR - Iran 18
VE - Venezuela 18
AT - Austria 15
MA - Marocco 14
PY - Paraguay 14
CZ - Repubblica Ceca 12
AU - Australia 11
AZ - Azerbaigian 11
JM - Giamaica 11
LB - Libano 11
AL - Albania 9
JO - Giordania 9
SA - Arabia Saudita 9
TN - Tunisia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
EG - Egitto 8
BG - Bulgaria 7
BJ - Benin 7
EU - Europa 7
IL - Israele 7
LT - Lituania 7
HR - Croazia 6
PH - Filippine 6
TH - Thailandia 6
PA - Panama 5
PE - Perù 5
RO - Romania 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
CR - Costa Rica 3
GA - Gabon 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
PS - Palestinian Territory 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AO - Angola 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
CG - Congo 1
DK - Danimarca 1
GF - Guiana Francese 1
Totale 20.156
Salva come PNG Salva come JPEG
Città #
Dallas 1.424
Singapore 1.333
Santa Clara 1.032
Chandler 916
Dublin 728
Jacksonville 689
Moscow 596
San Jose 537
Ashburn 441
Chicago 334
Boardman 325
Catania 289
Abidjan 252
Cambridge 200
Lawrence 198
Andover 195
Beijing 185
Lauterbourg 181
Nanjing 180
Houston 178
Toronto 174
Hefei 164
Los Angeles 150
Dakar 130
Ho Chi Minh City 113
Wilmington 110
Seoul 101
Council Bluffs 99
Des Moines 87
Hanoi 87
Civitanova Marche 83
San Mateo 83
New York 72
Dong Ket 65
Shenyang 63
Nanchang 62
São Paulo 56
Grafing 53
Hebei 51
Ottawa 49
The Dalles 49
Bremen 47
Buffalo 45
Messina 45
Saint Petersburg 45
Columbus 44
Abuja 43
Changsha 38
Hong Kong 36
Jiaxing 35
Lagos 35
Orem 35
Munich 31
Tokyo 31
Palermo 30
Tianjin 30
Milan 29
Rome 28
Falls Church 27
Seattle 27
Rio de Janeiro 25
Warsaw 25
Helsinki 24
Atlanta 22
Brooklyn 22
Dearborn 22
Montreal 22
Amsterdam 20
Chennai 20
Denver 19
Florence 19
Johannesburg 19
Norwalk 19
Stockholm 19
Jakarta 18
Redwood City 17
Boston 16
Brussels 16
Curitiba 16
Jinan 16
Phoenix 16
Pune 16
Turku 16
Lissone 15
Poplar 15
Baghdad 14
Da Nang 14
Washington 14
Belo Horizonte 13
Guangzhou 13
Hangzhou 13
Nairobi 13
Port Harcourt 13
Kunming 12
Lahore 12
Liberty Lake 12
Mumbai 12
San Francisco 12
Irvine 11
London 11
Totale 13.458
Salva come PNG Salva come JPEG
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 295
Current drug treatments targeting dopamine D3 receptor 241
Dopaminergic-GABAergic interplay and alcohol binge drinking 234
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 221
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 219
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 186
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 185
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 185
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 184
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 181
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 179
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 177
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 175
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 169
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 164
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 163
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 163
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 161
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats 158
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 156
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 153
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 149
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 148
Particle identification with the 4 pi CHIMERA detector array 147
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 143
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 141
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders 141
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 138
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 138
Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications 136
Controversies in Glaucoma: Current Medical Treatment and Drug Development 136
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 135
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 133
Activity of dihydrothienopyridine S312 enantiomers on L-type calcium channels in isolated rat aorta and cerebral microvessels 133
Epigenetic drugs for Alzheimer's disease: hopes and challenges 131
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 130
Effects of phenformin on the proliferation of human tumor cell lines 130
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy 128
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 128
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 128
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 128
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 127
Evaluation of Neostigmine responsiveness with concentric-needle single fiber electromyography in myasthenia gravis: A comparative study 126
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin 125
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 125
Retinal protection and distribution of curcumin in vitro and in vivo 124
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 124
Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes 123
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 123
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 120
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 120
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 119
Linking the Price of Cancer Drug Treatments to Their Clinical Value 118
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia 118
P2X7 receptor antagonism: implications in diabetic retinopathy 117
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE 117
Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? 117
A THERAPEUTIC DOSAGE OF AMLODIPINE PREVENTS VASCULAR HYPOREACTIVITY INDUCED IN RATS BY LIPOPOLYSACCHARIDE 117
Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment 116
Abnormal vascular responses and cerebral reperfusion injury in ApoE-deficient mice on Western diet 116
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 116
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 115
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools 114
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 113
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 112
Isoflavones: estrogenic activity, biological effect and bioavailability 112
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 112
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 112
Analytical and experimental pharmacology, challenges ahead 110
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 110
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 109
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 107
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 106
An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting 106
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 104
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 102
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 101
Lipoprotein(a) serum levels in diabetic patients with retinopathy 101
Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine 101
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 101
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats 101
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 101
Pharmacological and genetic evidence of dopamine receptor 3-mediated vasoconstriction in isolated mouse aorta 100
Pleiotropic effects of glitazones: a double edge sword? 100
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 100
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 100
Genomic portrait of a sporadic amyotrophic lateral sclerosis case in a large spinocerebellar ataxia type 1 family 100
Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery 99
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 99
Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate 99
Preclinical study of the action of a calcium channel blocker during salt load 97
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 96
CALCIUM ANTAGONISTS AND ENDOTHELIAL FUNCTION: FOCUS ON NITRIC OXIDE AND ENDOTHELIN 95
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors 93
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis 93
Farmacologia dell’ossido nitrico 91
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1 90
Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases 90
New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease-modifying drugs 90
Searching for disease-modifying drugs in AD: can we combine neuropsychological tools with biological markers? 88
Totale 13.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.089
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 0 160 130
2021/20221.549 198 211 28 25 227 53 217 57 148 8 59 318
2022/20232.734 232 124 40 279 277 463 30 511 621 15 88 54
2023/2024992 60 149 54 73 36 208 17 62 8 17 187 121
2024/20254.022 51 626 214 248 911 464 115 174 297 389 282 251
2025/20268.117 463 365 1.550 521 1.314 1.622 1.000 170 411 436 265 0
Totale 20.535